MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0010679
Brassica Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.78 Cr
▼ 18% YoY
Net loss · FY 2025
₹4.71 Cr
Net margin -19%
EBITDA · FY 2025
-₹2.64 Cr
EBITDA margin -10.7%
Authorised capital
₹7.5 Cr
Registered with MCA
Paid-up capital
₹5.76 Cr
Issued & subscribed
Open charges
₹15.09 Cr
Satisfied ₹34.94 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
155
Provident fund records
About Brassica Pharma Private Limited
Data last updated:
Brassica Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 February 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2006PTC160053. Its GSTIN is 27AACCB8097P1ZV (Maharashtra).
The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹5.76 Cr. It is led by directors Uday Suresh Chile and Jayashree Manohar Sirsavkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.78 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net loss of ₹4.71 Cr (net margin -19%) and EBITDA of -₹2.64 Cr (EBITDA margin -10.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 1% over five years.
The company has about 155 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: OptaZoom. As per MCA filings, the company has open charges of ₹15.09 Cr and satisfied charges of ₹34.94 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 2 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in October 2018. Its 3 peer companies in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Artura Pharmaceuticals Private Limited with revenue of ₹24.89 Cr. The company has 18 MSME Form 1 returns on record between 2015 and 2024, listing 2,692 overdue payments to 98 micro and small suppliers.
Brassica Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0010679). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brassicapharma.com.
Company details
CIN U24230MH2006PTC160053
Registration Number 160053
Incorporation Date 27 February 2006
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0010679
Recognitions & Rankings of Brassica Pharma
Contact details
Brassica Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is brassicapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address701/702 7th Floor Vastubh Apartment Off Road To Carter Road No 1 Nr. Subway, Borivli E, Mumbai, Maharashtra, India – 400066
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Brassica Pharma Private Limited, buy the company report.
Comprehensive company report
Brassica Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Brassica Pharma operates one associated brand: OptaZoom. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers a comprehensive B2B marketplace for eye care professionals. | optazoom.com |
Business activity
The main business activity of Brassica Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Brassica Pharma Private Limited, buy the company report.
Financials of Brassica Pharma Private Limited
FY 2025 filings availableBrassica Pharma Private Limited reported revenue of ₹24.78 Cr (down 18% YoY) for FY 2025.
Revenue · FY 2025
₹24.78 Cr ▼ 18%
Net loss · FY 2025
₹4.71 Cr margin -19%
EBITDA · FY 2025
-₹2.64 Cr margin -10.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 10%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 180%
3 years · compounded
▼ 46%
5 years · compounded
▼ 22%
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 180% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.71 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.7% | ||||
| Net Profit Margin | -19% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brassica Pharma Private Limited, buy the company report.
Board of directors of Brassica Pharma Private Limited
Brassica Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uday Suresh Chile | Director | 27 Feb 2006 | 20 Years 8 Months | Current |
| Jayashree Manohar Sirsavkar | Director | 27 Feb 2006 | 20 Years 8 Months | Current |
Peer comparison
Brassica Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Artura Pharmaceuticals Private Limited | ₹24.89 Cr (FY 2024) | 37.0% | Chennai, Tamil Nadu, India | |||
| Brassica Pharma Private Limitedthis company | ₹24.78 Cr (FY 2025) | -₹4.71 Cr | -19% | -18.0% | 155 | Mumbai, Maharashtra, India |
| Omni-Protech Drugs Private Limited | ₹24.63 Cr (FY 2025) | 4.0% | Pune, Maharashtra, India | |||
| Evinz Drugs Private Limited | ₹24.63 Cr (FY 2020) | 5.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Brassica Pharma Private Limited, buy the company report.
Auditor
Brassica Pharma Private Limited is audited by J G DALAL And CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J G DALAL And CO | FY 2024 | 102034W |
Shareholding
The shareholding of Brassica Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Brassica Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15.09 Cr
Satisfied charges
₹34.94 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2024 | 100915012 | Axis Bank Limited | ₹15 Cr | Open | |
| 31 Mar 2023 | 100708676 | Others | ₹8.6 Lakh | Open | |
| 07 Jan 2022 | 100525017 | Abhyudaya Co-Operative Bank Limited | ₹1.5 Cr | Satisfied | |
| 12 Oct 2020 | 100380470 | Abhyudaya Co-Operative Bank Limited | ₹45 Lakh | Satisfied | |
| 25 Sep 2020 | 100381332 | Abhyudaya Co-Operative Bank Limited | ₹20 Lakh | Satisfied |
To see the full charge records of Brassica Pharma Private Limited, buy the company report.
Total charge records: 13 View all charges
Deals & funding
Brassica Pharma Private Limited has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in October 2018.
Total deals
3
Secondary share transfers
2
Rights issue
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2016 | Rights issue | ₹2.15 Cr | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Brassica Pharma Private Limited has 6 court cases on record: 2 filed by Brassica Pharma, 4 filed against it. 2 cases are pending and 4 are disposed.
Total cases
6
Filed by the company
2
Filed against the company
4
Pending
2
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
| High courts | 3 | 1 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Appln.PGA) | Filed against the company by an individual | Pending |
| Bombay High Court | Court case (MCA) | Filed by the company against an individual | Disposed |
| High Court, MAHARASHTRA | Criminal complaint | Filed by the company against an individual | Disposed |
| Bombay High Court | Court case (S) | Filed against the company | Disposed |
To see the full case history of Brassica Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Brassica Pharma Private Limited has 18 MSME Form 1 returns on record between 2015 and 2024, listing 2,692 overdue payments to 98 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 98)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Alchemie Gases and Chemicals Pvt.Ltd. | |||
| Perfect Containers Private Limited | |||
| Manisha Analytical Laboratories Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Brassica Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Brassica Pharma Private Limited has a workforce of 155 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
155
Active EPFO establishments
1
Employee growth
-8.8%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 155 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Brassica Pharma Private Limited, buy the company report.
GST
Brassica Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCB8097P1ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Brassica Pharma Private Limited, buy the company report.
Recent activity
Brassica Pharma Private Limited has 3 board changes on record since 2006: 2 appointments and 1 cessation. The latest: Manohar Dattatraya Sirsavkar ceased to be Director on 10 Dec 2017.
AGM
Brassica Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Brassica Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 07 Jan 2022 via Charge ID 100525017 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 28 Jun 2024.
Charges
A charge registered on 23 Sep 2015 via Charge ID 10595711 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 28 Jun 2024.
Charges
A charge registered on 12 Jul 2012 via Charge ID 10371153 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 28 Jun 2024.
Charges
A charge registered on 22 Feb 2012 via Charge ID 10345221 with Abhyudaya Co-Op. Bank Ltd was fully satisfied on 28 Jun 2024.
Charges
A charge registered on 22 Feb 2012 via Charge ID 10345225 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 28 Jun 2024.
Charges
A charge registered on 22 Feb 2012 via Charge ID 10345058 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 28 Jun 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 15.00 Cr with Charge ID 100915012 was registered on 27 Mar 2024.
Charges
A charge registered on 08 Aug 2019 via Charge ID 100293543 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 22 Dec 2023.
Charges
A charge with Others amounted to Rs. 0.09 Cr with Charge ID 100708676 was registered on 31 Mar 2023.
Charges
A charge registered on 12 Oct 2020 via Charge ID 100380470 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 13 Dec 2022.
21 earlier events are in the company report.
Frequently asked questions
Brassica Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 February 2006 (20+ years old) and is registered under CIN U24230MH2006PTC160053.
Brassica Pharma has 2 current directors:
- Uday Suresh Chile - Director
- Jayashree Manohar Sirsavkar - Director
The latest financial statements of Brassica Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Brassica Pharma is 27AACCB8097P1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Brassica Pharma is U24230MH2006PTC160053. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brassica Pharma has 6 court cases on record: 2 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Brassica Pharma was incorporated on 27 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Brassica Pharma has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in October 2018.
The peers of Brassica Pharma by revenue are Artura Pharmaceuticals Private Limited, Omni-Protech Drugs Private Limited, Evinz Drugs Private Limited, all in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manohar Dattatraya Sirsavkar ceased to be Director on 10 Dec 2017. Jayashree Manohar Sirsavkar was appointed as Director on 27 Feb 2006. Uday Suresh Chile was appointed as Director on 27 Feb 2006.
Yes, Brassica Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0010679).
Brassica Pharma has 18 MSME Form 1 returns on record between 2015 and 2024, listing 2,692 overdue payments to 98 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages